Int J Biol Sci
2023; 19(15):4831-4832.
doi:10.7150/ijbs.89237 This issueCite
Commentary
p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer
Martin Fischer✉
Computational Biology Group, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11, 07745 Jena, Germany
✉ Corresponding author: Martin.Fischerde.
Citation:
Fischer M. p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer. Int J Biol Sci 2023; 19(15):4831-4832. doi:10.7150/ijbs.89237. https://www.ijbs.com/v19p4831.htm
The transcription factors p53 and MYC are often considered non-druggable targets, but their dysregulation can generate new dependencies and treatment opportunities in cancer cells. The p53 and MYC-regulated squalene epoxidase (SQLE) has been identified as a potential Achilles heel in colorectal cancer. This is of great interest because the FDA-approved anti-fungal SQLE inhibitor Terbinafine could be repurposed to treat colorectal cancer patients.
Fischer, M. (2023). p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer. International Journal of Biological Sciences, 19(15), 4831-4832. https://doi.org/10.7150/ijbs.89237.
ACS
Fischer, M. p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer. Int. J. Biol. Sci. 2023, 19 (15), 4831-4832. DOI: 10.7150/ijbs.89237.
NLM
Fischer M. p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer. Int J Biol Sci 2023; 19(15):4831-4832. doi:10.7150/ijbs.89237. https://www.ijbs.com/v19p4831.htm
CSE
Fischer M. 2023. p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer. Int J Biol Sci. 19(15):4831-4832.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Global reach, higher impact
